Thomas Ciulla

Position	Company	Period
Chief Medical Officer	Clearside Biomedical Inc	Oct. 1, 2018 - Dec. 31, 2018

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-01-20	2023-01-20	Clearside Biomedical Inc (CLSD)	PlS Planned sale	64,485 -37.6% 250.16 US$1,867,900	64,485 -37.6%	250.16	US$1,867,900
2023-01-11	2023-01-10	Clearside Biomedical Inc (CLSD)	PlS Planned sale	2,544 -5.6% 259.99 US$370,752	2,544 -5.6%	259.99	US$370,752
2022-01-20	2022-01-19	Clearside Biomedical Inc (CLSD)	PlS Planned sale	63,803 +37.7% 67.24 US$1,660,702	63,803 +37.7%	67.24	US$1,660,702